New Diagnostic Testing Company, Blue Ocean Biomedical, Specializes In Automated, Load & Go Cell Analysis Systems For Immune Monitoring

Share Article

Blue Ocean Biomedical will bring to market the world’s first fully automated, “patient-sample-to-result” systems for many specialized cell analysis tests that are in greatest demand worldwide.

The Blue Ocean CR Series: the first fully integrated, fluorescence-based, cellular analysis research systems dedicated to running standardized immune monitoring panels.

“Cellular analysis labs around the world require assays that are simpler, more standardized and more automated”, said Mike Brochu, CEO of Blue Ocean Biomedical.

Blue Ocean Biomedical, LLC, will bring to market the world’s first fully automated, “patient-sample-to-result” systems for many specialized cell analysis tests that are in greatest demand worldwide.

Blue Ocean Biomedical is a privately-held company headquartered in Pembroke Pines, FL. "Blue Ocean will lower the cost of healthcare by providing fully automated, 'load & go'(TM) diagnostic systems that greatly simplify patient testing in clinical and research laboratories around the world," said president Ernie Thomas. The Blue Ocean systems automate a number of expensive, specialized tests, such as HIV monitoring and extended WBC differential analysis tests. These kinds of tests are currently performed on complex flow cytometry systems that are designed for general use and require many time-consuming, manual steps which require a highly trained and experienced operator.

Blue Ocean changes all that with an innovative, automated, load & go approach. Blue Ocean systems are optimized to address needs for specific moderate-to-high-demand applications where test results are desired in less time, with greater efficiency and at substantially lower costs. This is accomplished via smart system design, proprietary technology, fewer required reagents and a low cost of delivering the product and support to end users. The new systems will, for the first time, combine automated sample preparation and analysis in one instrument that communicates with the laboratory’s computer system (LIS). Because it is standardized to run specific tests, instrument and test setup is minimized. As a result, Blue Ocean systems require minimal operator steps, greatly reduce the opportunities for user error, and provide fast and efficient specimen processing.

Blue Ocean will be displaying their new CR Series Immune Monitoring Systems for the first time at the ISAC CYTO 2010 show, the XXV Congress of the International Society for Advancement of Cytometry (http://cytoconference.org/pages/aboutISAC2010.aspx ).

Experienced, Proven Management Team

Blue Ocean Biomedical has brought together a team of professionals from the diagnostic systems industry. The team has strong credentials and expertise in all the key disciplines: software and systems development, mechanical and electrical engineering, reagents, quality assurance, regulatory affairs, manufacturing, marketing and laboratory management. Having worked together for years to provide contract development of a number of innovative and successful cell analysis systems for industry leading companies, this Blue Ocean team has developed a cohesive, team approach, capitalizing on the strengths of each member. They are focused and driven to achieve their goal: to bring load & go capabilities to a targeted range clinical and research testing applications.

The Blue Ocean team is led by CEO Mike Brochu, Sr., MBA, a 30-year biomedical industry veteran with executive experience in business development, strategic alliances, service and marketing (Coulter Corp.) Brochu is well paired with President Ernie Thomas, MBA, who applies a sharp entrepreneurial drive with a solid knowledge of the diagnostic industry market, players and technologies.

New Blue Ocean Website

Blue Ocean has introduced a new Website: http://www.blueoceanbio.com. The Website provides further information about the company, management team, products, reagents, consumables, applications, assay development partners and more.

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Arthur Lyons
Visit website